Table 3.
Laboratory parameters for ACEi/ARB versus Non-ACEi/ARB patients.
| Parameter | Statistics | Baseline | Follow-up (7–10 days) | Change | P-value | |||
|---|---|---|---|---|---|---|---|---|
| ACEI/ARB | No ACEI/ARB |
ACEI/ARB | No ACEI/ARB |
ACEI/ARB | No ACEI/ARB |
|||
|
Number of
patients |
N | 36 | 84 | 36 | 84 | 36 | 84 | |
| eGFR | Mean (SD) |
58.8 (27.56) |
65.0 (31.34) |
73.4 (27.05) |
72.6 (33.70) |
14.6 (15.71) |
7.6 (20.18) |
.10 |
| D-Dimer | Medium (Ranges) |
0.8 (0.3–5.5) |
0.6 (0.3–10.7) |
0.8 (0.3–4.0) |
0.5 (0.3–10.7) |
−0.3 (−2.1–0.4) |
0.0 (−4.4–6.1) |
.01 |
| Albumin | Medium (Ranges) |
63.0 (46.0–71.0) |
65.0 (50.0–89.0) |
59.0 (46.0–70.0) |
61.5 (42.0–72.0) |
−2.0 (−14.0–18.0) |
0.0 (−24.0–6.0) |
.60 |
| Protein | Medium (Ranges) |
35.0 (28.0–44.0) |
37.0 (25.0–48.0) |
34.0 (25.0–41.0) |
34.0 (25.0–48.0) |
−1.5 (−9.0–13.0) |
0.0 (−16.0–8.0) |
.43 |
ACEI/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, eGFR = estimated glomerular filtration rate, DF = degrees of freedom, SD = standard deviation.
*From ANOVA model with measurement at Visit2 as dependent, measurement at Baseline as covariate, and RAAS as fixed effect factor.
Estimates are based on the number of subjects with non-missing data.